Skip to the main content.
About Us

BMES serves as the lead society and professional home for biomedical engineers and bioengineers. BMES membership has grown to over 6,000 members, with more than 160 BMES Student Chapters, three Special Interest Groups (SIGs), and four professional journals.

BMES Hub

Welcome to the BMES Hub, a cutting-edge collaborative platform created to connect members, foster innovation, and facilitate conversations within the biomedical engineering community.

BMES Hub

Sponsor & Exhibitor Prospectus

Discover all of the ways that you can boost your presence and ROI at the 2024 BMES Annual Meeting. Browse a range of on-site and digital promotional opportunities designed to suit any goal or budget that will provide maximum impact.

1 min read

UNIVERSITY OF BUFFALO SPINOFF COMPANY WINS CONTRACT TO DEVELOP HIV VACCINE

A University at Buffalo spinoff company has received a $600,000 contract from the National Institutes of Health to pursue development of a vaccine against HIV, the university announced.

The technology, developed by POP Biotechnologies Inc., spontaneously converts high-quality HIV-derived proteins into virus-resembling particles, according to the announcement.

BMES member Jonathan F. Lovell, PhD, is the co-founder of POP BIO and an associate professor of biomedical engineering.

The funding — a Phase I Small Business Innovation Research contract with the National Institute of Allergy and Infectious Diseases — supports a collaboration between POP BIO and Scripps Research, with the goal of using POP BIO's next-generation vaccine delivery platform to enhance the performance of vaccine antigens developed by scientists at Scripps Research.

The delivery platform, a liposome-based vaccine adjuvant, leverages technology that POP BIO has licensed from UB, according to the article.

POP BIO's vaccine delivery platform is called SNAP (Spontaneous Nanoliposome Antigen Particleization). SNAP consists of specialized liposomes, originally developed in Lovell's UB lab, that bind to and improve the effectiveness of vaccine antigens — molecules that prompt the body to produce antibodies that neutralize disease.

Read more HERE.

Call for Chapter Development Report Reviewers

Call for Chapter Development Report Reviewers

Want to make an impact? As a CDR reviewer, you’ll evaluate submissions from student chapters and help determine which ones deserve top recognition....

Read More
BMES 2025 Call for Abstracts Now Open

BMES 2025 Call for Abstracts Now Open

We’re looking forward to seeing you in San Diego, CA., on October 8-11 for #BMES2025.

Read More
Call for Awards & Fellows Committee Members

Call for Awards & Fellows Committee Members

We are seeking passionate members to join the prestigious BMES Awards and Fellows committees and play a key role in helping us recognize excellence...

Read More
PAPER DEVICE DEVELOPED AT PURDUE COULD BRING PORTABLE CORONAVIRUS DETECTION

PAPER DEVICE DEVELOPED AT PURDUE COULD BRING PORTABLE CORONAVIRUS DETECTION

Purdue University biomedical engineers have developed a handheld paper device that quickly and accurately detects a different strain of coronavirus,...

Read More
PURDUE RESEARCHERS DEVELOP TECHNOLOGY FOR PATHOGEN DETECTION DRIVEN BY LASERS

1 min read

PURDUE RESEARCHERS DEVELOP TECHNOLOGY FOR PATHOGEN DETECTION DRIVEN BY LASERS

Purdue University researchers have developed new technology to help stop the spread of foodborne illnesses by detecting them more efficiently.The...

Read More
U OF MINN. STUDY ON MOLECULAR INTERACTIONS COULD IMPROVE DEVELOPMENT OF NEW MEDICINES FOR CANCER

1 min read

U OF MINN. STUDY ON MOLECULAR INTERACTIONS COULD IMPROVE DEVELOPMENT OF NEW MEDICINES FOR CANCER

A study on molecular interactions by biomedical engineers in the University of Minnesota's College of Science and Engineering will make it easier and...

Read More